Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.
Published August 16, 2017 · Recall initiated: July 26, 2017
Summary
FDA records drug Class II recall D-1082-2017, published August 16, 2017 and initiated July 26, 2017. Recalling firm: HOSPIRA INC, LAKE FOREST; Status: Terminated; Reported quantity: 56,340 vials; Lot: Lot #: 560103F, Exp. 01AUG2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Silicone oil
What to do
Voluntary: Firm initiated · Telephone
Get an email if HYDROMORPHONE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROMORPHONE HYDROCHLORIDE
- Manufacturer
- HOSPIRA INC, LAKE FOREST
- Distributor
- Nationwide in the USA
- UPC
- 0307030110038
- Lot
- Lot #: 560103F, Exp. 01AUG2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High PotencyMarch 21, 2018
- FDAHYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only,September 27, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: TevaAugust 16, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100August 16, 2017
- FDAWhole Foods Market PB & J Parfait Made With Greek Yogurt; Net Wt 8 OZ.;August 16, 2017
- FDAMCCAIN ONION RING BATTERED PORTION PERFECT ¿ 60X4 ozAugust 16, 2017
Questions about this recall
Was Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. recalled?
Yes. FDA published recall D-1082-2017 on August 16, 2017. Reported hazard: Presence of Particulate Matter: Silicone oil
What should I do if I have this product?
Voluntary: Firm initiated · Telephone
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROMORPHONE HYDROCHLORIDE. UPC: 0307030110038.